“Imane Khelif is a real woman,” declared a physiology lecturer, Prof Dr Rafidah Hanim Mokhtarat from Universiti Sains Islam Malaysia’s Faculty of Medicine and Health Sciences. This statement addresses the swirling controversy surrounding the Algerian female boxer competing in the Paris 2024 Olympic Games, who has been subject to scrutiny due to her masculine appearance.
The debate intensified recently when Imane Khelif faced off against her Italian opponent, Angela Carini. Within the first 40 seconds of the round, Carini was overwhelmed and subsequently withdrew from the match. Khelif, one of the 16 competitors in the women’s welterweight event, finds herself at the centre of a gender eligibility dispute.
Questions about Khelif’s gender identity have been rampant. Is she a transgender athlete? Or does she fall under the category of having Differences in Sex Development (DSD)? According to experts, Khelif was raised and registered as female, thus she is not transgender. She has consistently competed in women’s events. However, a gender qualification test conducted by the International Boxing Association in 2023 revealed that she possesses XY chromosomes.
This revelation has added fuel to the fire of an already heated debate. Many female athletes have protested against male athletes competing in women’s events, prompting more stringent gender qualification tests.
Experts suggest that Khelif’s condition might be categorised as DSD 46 XY with a deficiency of the 5-alpha-reductase hormone (5-ARD). This condition can lead to significant body changes due to androgen levels, akin to what Khelif experiences.
Individuals with DSD 5-ARD often have ambiguous or female genitalia at birth, leading them to be raised as females. However, during puberty, they experience high androgen levels, known as hyperandrogenism, resulting in increased testosterone levels. This provides them with physical advantages similar to those of males, such as increased muscle mass and bone density.
The International Olympic Committee (IOC) has defended its decision to allow Khelif and another female boxer to compete in the Paris Olympics despite ongoing gender disputes. The IOC’s stance has sparked further debate about fairness and equality in sports.
The controversy surrounding Khelif’s participation has not gone unnoticed in her home country. Algerian officials condemned what they described as “lies” about her eligibility. The village where Khelif grew up hails her as a heroine, championing her right to compete.
Khelif herself has remained resolute amidst the controversy, stating unequivocally, “I am a woman, always a woman.” Her determination to compete and win is undeterred by the scrutiny she faces.
The issue of gender eligibility in sports is not new. In recent years, there have been several high-profile cases involving athletes with DSD or hyperandrogenism. These cases have raised complex questions about fairness, inclusivity, and the nature of competition.
For instance, two boxers who failed gender tests at the World Championships were later cleared to compete in the Olympic Games. These decisions often spark intense debate among athletes, sporting bodies, and the public.
Experts argue that while it’s crucial to ensure fair competition, it’s equally important to respect the rights and identities of all athletes. The challenge lies in finding a balance between these competing priorities.
The case of Imane Khelif highlights the complexities of this issue. As a boxer with DSD 5-ARD, she naturally produces higher levels of testosterone than typical female athletes. This gives her certain physical advantages, but it does not change her gender identity or her right to compete as a woman.
The physiological differences between male and female athletes are well-documented. Men generally have higher levels of testosterone, which contributes to greater muscle mass and strength. However, there is significant variation within each gender, and some women naturally produce higher levels of testosterone than others.
In recent years, sporting bodies have introduced various policies to address these differences. For example, some organisations require athletes with high testosterone levels to undergo hormone therapy to lower their levels before they can compete in women’s events. These policies are controversial and have been criticised for being invasive and discriminatory.
Research on DSD and hyperandrogenism continues to evolve, providing new insights into these conditions and their impact on athletic performance. However, there is still much that scientists do not understand. This uncertainty adds another layer of complexity to the debate about gender eligibility in sports.
The case of Imane Khelif underscores the need for a nuanced approach to these issues. Rather than relying solely on genetic tests or hormone levels, experts argue for a more holistic assessment that considers an athlete’s overall physiology, identity, and life experiences.
As the debate continues, it’s clear that there are no easy answers. The goal should be to create a sporting environment that is fair, inclusive, and respectful of all athletes. This requires ongoing dialogue, research, and a willingness to adapt policies as new information becomes available.
Imane Khelif’s journey in the Paris 2024 Olympic Games shines a spotlight on the complex interplay between gender identity and athletic performance. Her story is a testament to resilience and determination in the face of adversity. As we continue to grapple with these issues, it’s important to remember that at the heart of this debate are real people with real lives and aspirations.
